Understanding the Changing Exposure and Toxicity Profile of Engineered Nanomaterials from Production to Application
Public Domain
-
2019/03/01
-
By Erdely A
Details
-
Personal Author:
-
Description:Engineered nanomaterials, because of their electrical, chemical, and thermal properties, are being incorporated into existing, everyday products, with broad applications to medicine, electronics, composites, and construction. From smart phones, to water purification, to cosmetics, to thermoplastics (e.g., toys, containers), human exposure to engineered nanomaterials and their applications is inevitable. It is critical that interpretations of potential toxicity along the product value chain be exposure-informed as TSCA requires a risk evaluation at all points along the life cycle of a chemical. Properly understanding and developing risk profiles for workers and end-users are necessary to prevent unintended health consequences. Engineered nanomaterial research initially focused on as-produced (pristine) material with little attention to downstream applications. Given the broad applications of nanomaterials into existing and emerging technologies, a more expansive characterization of exposure was needed to understand potential health risks. To accomplish this goal, a multidisciplinary team with private sector partnerships was needed. This work will describe a comprehensive case study evaluating carbon nanotubes, which represent a highly visible engineered nanomaterial due to the significant toxicity observed following in vivo evaluations. The work evaluates the changing toxicity and exposure characteristics along the product value chain from the as-produced material, to post-production modification, to matrix (or product) incorporation. The results clearly indicate that exposure and toxicity, and thus potential risks to workers and end users can be quite different from product to product. Understanding the changing exposure profile of engineered nanomaterials along the product value chain is critical for determining potential human health risks and overcoming risk-driven concerns that are potential barriers to increased commercialization. The case study also provides a framework and recommendations for evaluating other materials and scenarios, develops reproducible methods, and highlights new, or alterations to existing, methodology to characterize exposure and toxicity at different points along the product value chain. The comprehensive approach of combining toxicity and exposure assessments is necessary to provide direct inference to potential consumer risks. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:168
-
Issue:1
-
NIOSHTIC Number:nn:20055075
-
Citation:Toxicologist 2019 Mar; 168(1):500
-
CAS Registry Number:
-
Federal Fiscal Year:2019
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:The Toxicologist. Society of Toxicology 58th Annual Meeting and ToxExpo, March 10-14, 2019, Baltimore, Maryland
-
Collection(s):
-
Main Document Checksum:urn:sha-512:63f444aa5824d1714a144adbe26071c0c95056ac2622c67b9bb48d2a6cd3f51279edd7a410820a215f618ff6d24b84be55955fb1ee4724f948a4306df12b8aae
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like